Global Hematologic Malignancies Market 2018-2024: Opportunities, Future Trends, Growing Demand, Analysis, Forecast & Industry Developments

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Sep-2018   |    Format :PDF   |    Number of Pages : 99
This report focuses on the global Hematologic Malignancies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hematologic Malignancies development in United States, Europe and China.

In 2017, the global Hematologic Malignancies market size was  million US$ and it is expected to reach  million US$ by the end of 2025, with a CAGR of  during 2018-2025.

The key players covered in this study
    Pfizer, Inc.
    F. Hoffmann-LA Roche ltd
    Sanofi-Aventis
    Bristol-Myers Squibb Company
    AbbVie, Inc.
    Novartis AG
    GlaxoSmithKline PLC
    Celgene Corporation
    Johnson & Johnson Services, Inc.
    Takeda Pharmaceutical Company limited

Market segment by Type, the product can be split into
    Leukemia
    Lymphoma
    Multiple Myeloma
    Others

Market segment by Application, split into
    Chemotherapy
    Radiotherapy
    Immunotherapy
    Stem Cell Transplantation
    Others

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Hematologic Malignancies status, future forecast, growth opportunity, key market and key players.
    To present the Hematologic Malignancies development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hematologic Malignancies are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Hematologic Malignancies Market Size Growth Rate by Type (2013-2025)
        1.4.2 Leukemia
        1.4.3 Lymphoma
        1.4.4 Multiple Myeloma
        1.4.5 Others
    1.5 Market by Application
        1.5.1 Global Hematologic Malignancies Market Share by Application (2013-2025)
        1.5.2 Chemotherapy
        1.5.3 Radiotherapy
        1.5.4 Immunotherapy
        1.5.5 Stem Cell Transplantation
        1.5.6 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Hematologic Malignancies Market Size
    2.2 Hematologic Malignancies Growth Trends by Regions
        2.2.1 Hematologic Malignancies Market Size by Regions (2013-2025)
        2.2.2 Hematologic Malignancies Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Hematologic Malignancies Market Size by Manufacturers
        3.1.1 Global Hematologic Malignancies Revenue by Manufacturers (2013-2018)
        3.1.2 Global Hematologic Malignancies Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Hematologic Malignancies Market Concentration Ratio (CR5 and HHI)
    3.2 Hematologic Malignancies Key Players Head office and Area Served
    3.3 Key Players Hematologic Malignancies Product/Solution/Service
    3.4 Date of Enter into Hematologic Malignancies Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Hematologic Malignancies Market Size by Type (2013-2018)
    4.2 Global Hematologic Malignancies Market Size by Application (2013-2018)

5 United States
    5.1 United States Hematologic Malignancies Market Size (2013-2018)
    5.2 Hematologic Malignancies Key Players in United States
    5.3 United States Hematologic Malignancies Market Size by Type
    5.4 United States Hematologic Malignancies Market Size by Application

6 Europe
    6.1 Europe Hematologic Malignancies Market Size (2013-2018)
    6.2 Hematologic Malignancies Key Players in Europe
    6.3 Europe Hematologic Malignancies Market Size by Type
    6.4 Europe Hematologic Malignancies Market Size by Application

7 China
    7.1 China Hematologic Malignancies Market Size (2013-2018)
    7.2 Hematologic Malignancies Key Players in China
    7.3 China Hematologic Malignancies Market Size by Type
    7.4 China Hematologic Malignancies Market Size by Application

8 Japan
    8.1 Japan Hematologic Malignancies Market Size (2013-2018)
    8.2 Hematologic Malignancies Key Players in Japan
    8.3 Japan Hematologic Malignancies Market Size by Type
    8.4 Japan Hematologic Malignancies Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Hematologic Malignancies Market Size (2013-2018)
    9.2 Hematologic Malignancies Key Players in Southeast Asia
    9.3 Southeast Asia Hematologic Malignancies Market Size by Type
    9.4 Southeast Asia Hematologic Malignancies Market Size by Application

10 India
    10.1 India Hematologic Malignancies Market Size (2013-2018)
    10.2 Hematologic Malignancies Key Players in India
    10.3 India Hematologic Malignancies Market Size by Type
    10.4 India Hematologic Malignancies Market Size by Application

11 Central & South America
    11.1 Central & South America Hematologic Malignancies Market Size (2013-2018)
    11.2 Hematologic Malignancies Key Players in Central & South America
    11.3 Central & South America Hematologic Malignancies Market Size by Type
    11.4 Central & South America Hematologic Malignancies Market Size by Application

12 International Players Profiles
    12.1 Pfizer, Inc.
        12.1.1 Pfizer, Inc. Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Hematologic Malignancies Introduction
        12.1.4 Pfizer, Inc. Revenue in Hematologic Malignancies Business (2013-2018)
        12.1.5 Pfizer, Inc. Recent Development
    12.2 F. Hoffmann-LA Roche ltd
        12.2.1 F. Hoffmann-LA Roche ltd Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Hematologic Malignancies Introduction
        12.2.4 F. Hoffmann-LA Roche ltd Revenue in Hematologic Malignancies Business (2013-2018)
        12.2.5 F. Hoffmann-LA Roche ltd Recent Development
    12.3 Sanofi-Aventis
        12.3.1 Sanofi-Aventis Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Hematologic Malignancies Introduction
        12.3.4 Sanofi-Aventis Revenue in Hematologic Malignancies Business (2013-2018)
        12.3.5 Sanofi-Aventis Recent Development
    12.4 Bristol-Myers Squibb Company
        12.4.1 Bristol-Myers Squibb Company Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Hematologic Malignancies Introduction
        12.4.4 Bristol-Myers Squibb Company Revenue in Hematologic Malignancies Business (2013-2018)
        12.4.5 Bristol-Myers Squibb Company Recent Development
    12.5 AbbVie, Inc.
        12.5.1 AbbVie, Inc. Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Hematologic Malignancies Introduction
        12.5.4 AbbVie, Inc. Revenue in Hematologic Malignancies Business (2013-2018)
        12.5.5 AbbVie, Inc. Recent Development
    12.6 Novartis AG
        12.6.1 Novartis AG Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Hematologic Malignancies Introduction
        12.6.4 Novartis AG Revenue in Hematologic Malignancies Business (2013-2018)
        12.6.5 Novartis AG Recent Development
    12.7 GlaxoSmithKline PLC
        12.7.1 GlaxoSmithKline PLC Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Hematologic Malignancies Introduction
        12.7.4 GlaxoSmithKline PLC Revenue in Hematologic Malignancies Business (2013-2018)
        12.7.5 GlaxoSmithKline PLC Recent Development
    12.8 Celgene Corporation
        12.8.1 Celgene Corporation Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Hematologic Malignancies Introduction
        12.8.4 Celgene Corporation Revenue in Hematologic Malignancies Business (2013-2018)
        12.8.5 Celgene Corporation Recent Development
    12.9 Johnson & Johnson Services, Inc.
        12.9.1 Johnson & Johnson Services, Inc. Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Hematologic Malignancies Introduction
        12.9.4 Johnson & Johnson Services, Inc. Revenue in Hematologic Malignancies Business (2013-2018)
        12.9.5 Johnson & Johnson Services, Inc. Recent Development
    12.10 Takeda Pharmaceutical Company limited
        12.10.1 Takeda Pharmaceutical Company limited Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 Hematologic Malignancies Introduction
        12.10.4 Takeda Pharmaceutical Company limited Revenue in Hematologic Malignancies Business (2013-2018)
        12.10.5 Takeda Pharmaceutical Company limited Recent Development

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details



List of Tables and Figures

    Table Hematologic Malignancies Key Market Segments
    Table Key Players Hematologic Malignancies Covered
    Table Global Hematologic Malignancies Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Hematologic Malignancies Market Size Market Share by Type 2013-2025
    Figure Leukemia Figures
    Table Key Players of Leukemia
    Figure Lymphoma Figures
    Table Key Players of Lymphoma
    Figure Multiple Myeloma Figures
    Table Key Players of Multiple Myeloma
    Figure Others Figures
    Table Key Players of Others
    Table Global Hematologic Malignancies Market Size Growth by Application 2013-2025 (Million US$)
    Figure Chemotherapy Case Studies
    Figure Radiotherapy Case Studies
    Figure Immunotherapy Case Studies
    Figure Stem Cell Transplantation Case Studies
    Figure Others Case Studies
    Figure Hematologic Malignancies Report Years Considered
    Table Global Hematologic Malignancies Market Size 2013-2025 (Million US$)
    Figure Global Hematologic Malignancies Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Hematologic Malignancies Market Size by Regions 2013-2025 (Million US$)
    Table Global Hematologic Malignancies Market Size by Regions 2013-2018 (Million US$)
    Table Global Hematologic Malignancies Market Share by Regions 2013-2018
    Figure Global Hematologic Malignancies Market Share by Regions 2013-2018
    Figure Global Hematologic Malignancies Market Share by Regions 2018
    Table Market Top Trends
    Table Global Hematologic Malignancies Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Hematologic Malignancies Market Share by Manufacturers (2013-2018)
    Figure Global Hematologic Malignancies Market Share by Manufacturers in 2018
    Table Global Hematologic Malignancies Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Hematologic Malignancies Product/Solution/Service
    Table Date of Enter into Hematologic Malignancies Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Hematologic Malignancies Market Size by Type (2013-2018) (Million US$)
    Table Global Hematologic Malignancies Market Size Share by Type (2013-2018)
    Figure Global Hematologic Malignancies Market Size Market Share by Type (2013-2018)
    Table Global Hematologic Malignancies Market Size by Application (2013-2018) (Million US$)
    Table Global Hematologic Malignancies Market Size Share by Application (2013-2018)
    Figure Global Hematologic Malignancies Market Size Market Share by Application (2013-2018)
    Figure Global Hematologic Malignancies Revenue Market Share by Application in 2017
    Figure United States Hematologic Malignancies Market Size 2013-2018 (Million US$)
    Table United States Key Players Hematologic Malignancies Revenue (2017-2018) (Million US$)
    Table United States Key Players Hematologic Malignancies Market Share (2017-2018)
    Table United States Hematologic Malignancies Market Size by Type (2013-2018) (Million US$)
    Table United States Hematologic Malignancies Market Share by Type (2013-2018)
    Table United States Hematologic Malignancies Market Size by Application (2013-2018) (Million US$)
    Table United States Hematologic Malignancies Market Share by Application (2013-2018)
    Figure Europe Hematologic Malignancies Market Size 2013-2018 (Million US$)
    Table Europe Key Players Hematologic Malignancies Revenue (2017-2018) (Million US$)
    Table Europe Key Players Hematologic Malignancies Market Share (2017-2018)
    Table Europe Hematologic Malignancies Market Size by Type (2013-2018) (Million US$)
    Table Europe Hematologic Malignancies Market Share by Type (2013-2018)
    Table Europe Hematologic Malignancies Market Size by Application (2013-2018) (Million US$)
    Table Europe Hematologic Malignancies Market Share by Application (2013-2018)
    Figure China Hematologic Malignancies Market Size 2013-2018 (Million US$)
    Table China Key Players Hematologic Malignancies Revenue (2017-2018) (Million US$)
    Table China Key Players Hematologic Malignancies Market Share (2017-2018)
    Table China Hematologic Malignancies Market Size by Type (2013-2018) (Million US$)
    Table China Hematologic Malignancies Market Share by Type (2013-2018)
    Table China Hematologic Malignancies Market Size by Application (2013-2018) (Million US$)
    Table China Hematologic Malignancies Market Share by Application (2013-2018)
    Figure Japan Hematologic Malignancies Market Size 2013-2018 (Million US$)
    Table Japan Key Players Hematologic Malignancies Revenue (2017-2018) (Million US$)
    Table Japan Key Players Hematologic Malignancies Market Share (2017-2018)
    Table Japan Hematologic Malignancies Market Size by Type (2013-2018) (Million US$)
    Table Japan Hematologic Malignancies Market Share by Type (2013-2018)
    Table Japan Hematologic Malignancies Market Size by Application (2013-2018) (Million US$)
    Table Japan Hematologic Malignancies Market Share by Application (2013-2018)
    Figure Southeast Asia Hematologic Malignancies Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Hematologic Malignancies Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Hematologic Malignancies Market Share (2017-2018)
    Table Southeast Asia Hematologic Malignancies Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Hematologic Malignancies Market Share by Type (2013-2018)
    Table Southeast Asia Hematologic Malignancies Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Hematologic Malignancies Market Share by Application (2013-2018)
    Figure India Hematologic Malignancies Market Size 2013-2018 (Million US$)
    Table India Key Players Hematologic Malignancies Revenue (2017-2018) (Million US$)
    Table India Key Players Hematologic Malignancies Market Share (2017-2018)
    Table India Hematologic Malignancies Market Size by Type (2013-2018) (Million US$)
    Table India Hematologic Malignancies Market Share by Type (2013-2018)
    Table India Hematologic Malignancies Market Size by Application (2013-2018) (Million US$)
    Table India Hematologic Malignancies Market Share by Application (2013-2018)
    Figure Central & South America Hematologic Malignancies Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Hematologic Malignancies Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Hematologic Malignancies Market Share (2017-2018)
    Table Central & South America Hematologic Malignancies Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Hematologic Malignancies Market Share by Type (2013-2018)
    Table Central & South America Hematologic Malignancies Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Hematologic Malignancies Market Share by Application (2013-2018)
    Table Pfizer, Inc. Company Details
    Table Pfizer, Inc. Revenue in Hematologic Malignancies Business (2013-2018) (Million US$)
    Figure Pfizer, Inc. Revenue Growth Rate in Hematologic Malignancies Business (2013-2018)
    Table Pfizer, Inc. Recent Development
    Table F. Hoffmann-LA Roche ltd Company Details
    Table F. Hoffmann-LA Roche ltd Revenue in Hematologic Malignancies Business (2013-2018)(Million US$)
    Figure F. Hoffmann-LA Roche ltd Revenue Growth Rate in Hematologic Malignancies Business (2013-2018)
    Table F. Hoffmann-LA Roche ltd Recent Development
    Table Sanofi-Aventis Company Details
    Table Sanofi-Aventis Revenue in Hematologic Malignancies Business (2013-2018)(Million US$)
    Figure Sanofi-Aventis Revenue Growth Rate in Hematologic Malignancies Business (2013-2018)
    Table Sanofi-Aventis Recent Development
    Table Bristol-Myers Squibb Company Company Details
    Table Bristol-Myers Squibb Company Revenue in Hematologic Malignancies Business (2013-2018)(Million US$)
    Figure Bristol-Myers Squibb Company Revenue Growth Rate in Hematologic Malignancies Business (2013-2018)
    Table Bristol-Myers Squibb Company Recent Development
    Table AbbVie, Inc. Company Details
    Table AbbVie, Inc. Revenue in Hematologic Malignancies Business (2013-2018)(Million US$)
    Figure AbbVie, Inc. Revenue Growth Rate in Hematologic Malignancies Business (2013-2018)
    Table AbbVie, Inc. Recent Development
    Table Novartis AG Company Details
    Table Novartis AG Revenue in Hematologic Malignancies Business (2013-2018)(Million US$)
    Figure Novartis AG Revenue Growth Rate in Hematologic Malignancies Business (2013-2018)
    Table Novartis AG Recent Development
    Table GlaxoSmithKline PLC Company Details
    Table GlaxoSmithKline PLC Revenue in Hematologic Malignancies Business (2013-2018)(Million US$)
    Figure GlaxoSmithKline PLC Revenue Growth Rate in Hematologic Malignancies Business (2013-2018)
    Table GlaxoSmithKline PLC Recent Development
    Table Celgene Corporation Company Details
    Table Celgene Corporation Revenue in Hematologic Malignancies Business (2013-2018)(Million US$)
    Figure Celgene Corporation Revenue Growth Rate in Hematologic Malignancies Business (2013-2018)
    Table Celgene Corporation Recent Development
    Table Johnson & Johnson Services, Inc. Company Details
    Table Johnson & Johnson Services, Inc. Revenue in Hematologic Malignancies Business (2013-2018)(Million US$)
    Figure Johnson & Johnson Services, Inc. Revenue Growth Rate in Hematologic Malignancies Business (2013-2018)
    Table Johnson & Johnson Services, Inc. Recent Development
    Table Takeda Pharmaceutical Company limited Company Details
    Table Takeda Pharmaceutical Company limited Revenue in Hematologic Malignancies Business (2013-2018)(Million US$)
    Figure Takeda Pharmaceutical Company limited Revenue Growth Rate in Hematologic Malignancies Business (2013-2018)
    Table Takeda Pharmaceutical Company limited Recent Development
    Table Global Hematologic Malignancies Market Size by Regions (Million US$) 2018-2025
    Figure Global Hematologic Malignancies Market Size Share by Regions (2018-2025)
    Figure Global Hematologic Malignancies Market Size Share by Regions in 2025
    Figure United States Hematologic Malignancies Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Hematologic Malignancies Market Size Forecast (2018-2025)(Million USD)
    Figure China Hematologic Malignancies Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Hematologic Malignancies Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Hematologic Malignancies Market Size Forecast (2018-2025)(Million USD)
    Figure India Hematologic Malignancies Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Hematologic Malignancies Market Size Forecast (2018-2025)(Million USD)
    Table Global Hematologic Malignancies Market Size by Product (2018-2025) (Million US$)
    Figure Global Hematologic Malignancies Market Size by Product (2018-2025)
    Figure Global Hematologic Malignancies Market Size by Product in 2025
    Table Global Hematologic Malignancies Market Size by Application (2018-2025) (Million US$)
    Figure Global Hematologic Malignancies Market Size by Application (2018-2025)
    Figure Global Hematologic Malignancies Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

25-Feb-2019 | Medical Devices

Launch Of Symjepi Epinephrine Syringe To Boost The Syringe Market Growth In US

A rising burden of chronic diseases has been observed all across the world, which, in turn, has elevated the usage of syringes. Overall, the global syringe market is anticipated to observe vigorous ...

25-Feb-2019 | Electrical & Electronic Device

Launch Of Xiaomi Set-Top Box To Power The Global 4K Set-Top Box Market

While smart TVs are turning out to be much more widespread these days, a number of consumers still choose to opt for normal TVs and then employ smart streaming set top box with them. Popular choice ...

13-Feb-2019 | Software

Bioinspired Artificial Bug Eye Creation Is A Baton For Global Autonomous Car Market

After looking at the different eye lens structures of the animals and humans, the researchers have decided on creating a sharp image using its design. The compound eyes of the bugs are currently be ...

13-Feb-2019 | Consumer Goods & Retailing

Cafe X’s $12 Million “Seed-1” Round To Boost The Global Coffee Market

Cafe X, a company engaged in building robot baristas, is about to raise a $12 Million “Seed-1” round. Recently, Crunchbase News broke the story when it came across regulatory f ...

05-Feb-2019 | Chemicals & Materials

Clinically Produced Cells Change The Horizon Of Global Bone Cement And Glue Market

The group of researchers from the New York Stem Cell Foundation Research Institute published an article in Stem Cell Research and Therapy where the details regarding the clinical ...